Fed. Circ. Won't Rehear Prandin Use Code Patent Case
Unmoved by calls from the generic-drug industry to revisit the decision, a federal appeals court has refused to reconsider en banc an April ruling for Novo Nordisk A/S in its patent...To view the full article, register now.
Already a subscriber? Click here to view full article